what are the DDx of a HEADACHE in a 25 year old male, the headache is continuous in nature and doesnt respond to OTC analgesics!?
differential diagnosis continuous headache young adult not responding to OTC analgesics

| Diagnosis | Key Features | OTC Response |
|---|---|---|
| Chronic Migraine | >15 headache days/month, unilateral/bilateral, throbbing, nausea/photo/phonophobia | Often inadequate - needs triptans, CGRP agents |
| New Daily Persistent Headache (NDPH) | Abrupt-onset continuous headache, exact date of onset recalled, no prior history | Poor to OTC; specific treatments needed |
| Chronic Tension-Type Headache | Bilateral, pressing/band-like, >15 days/month, no nausea | Often OTC-resistant when chronic |
| Hemicrania Continua | Strictly unilateral, continuous with superimposed jabs, ipsilateral autonomic features | Pathognomonic response to INDOMETHACIN only - not standard OTC NSAIDs |
| Medication Overuse Headache (MOH) | Paradoxically worsens with analgesic use >10-15 days/month; arises on a background of pre-existing headache | Worsens with OTC use |
| Cluster Headache | More frequent in men; severe unilateral periorbital pain, autonomic features; but typically episodic (30-90 min), not truly continuous | OTC ineffective; needs O₂, triptans, verapamil |
Find recent clinical guidelines on evaluating new-onset continuous headaches
"headache" AND "guideline" AND "evaluation"
"new daily persistent headache" OR "continuous headache" AND "diagnosis"
clinical guidelines new onset continuous headache evaluation 2023 2024 AAN EHF
PMID: 39467289
PMID: 37032616
"headache" AND "neuroimaging" AND "secondary" AND "red flags"
PMID: 38419454
PMID: 34894320
PMID: 40864527
ICHD-3 new daily persistent headache diagnostic criteria evaluation workup 2024
Critical point: Before NDPH can be diagnosed, ALL secondary causes must be excluded. ICHD-3 criterion 4 is non-negotiable - secondary headaches that mimic NDPH are common and dangerous.
| Letter | Red Flag |
|---|---|
| S | Systemic symptoms (fever, weight loss, night sweats) |
| N | Neoplasm history |
| N | Neurologic deficit or dysfunction |
| O | Onset sudden/abrupt (thunderclap) |
| O | Older age (>50 new onset) |
| P | Pattern change or progressive worsening |
| P | Papilledema |
| P | Positional headache |
| 1 | Precipitated by Valsalva/cough/exercise/sex |
| 0 | Post-traumatic onset |
| Suspected Cause | Recommended Imaging |
|---|---|
| SAH, hemorrhage | Non-contrast CT head first (within 6 hrs); if negative, LP or CT angiography |
| CVST | MRI brain + MRV |
| Mass lesion / IIH | MRI brain with and without contrast |
| Arterial dissection | MRI/MRA or CTA neck |
| Spontaneous intracranial hypotension | MRI brain with gadolinium (pachymeningeal enhancement) |
| No red flags present | Primary headache more likely; neuroimaging may not be needed |
Step 1: History
├── Onset: exact date/time recalled? (NDPH hallmark)
├── Was it truly sudden (thunderclap) → think SAH, RCVS, CVST
├── Character: migraine-like vs. tension-like vs. autonomic features
├── Positional component? Worse lying down = raised ICP; worse upright = low CSF pressure
├── Associated: fever, visual changes, focal deficits, weight loss
└── Medications: current and prior (exclude MOH)
Step 2: Physical Examination
├── BP measurement (mandatory)
├── Full neurological exam
└── Fundoscopy: papilledema = raised ICP until proven otherwise
Step 3: Imaging (if ANY red flag present)
├── CT head non-contrast → SAH, hemorrhage, acute hydrocephalus
├── MRI brain + gadolinium → mass, metastasis, SIH, meningitis
├── MRI + MRV → CVST
└── MRA/CTA neck → dissection
Step 4: LP (if indicated)
├── After negative CT in suspected SAH/meningitis
└── Opening pressure for IIH
Step 5: If all secondary causes excluded
└── Characterize primary disorder using ICHD-3 criteria
├── NDPH (exact onset recalled, continuous from day 1)
├── Chronic migraine
├── Hemicrania continua (indomethacin trial)
└── Chronic tension-type headache
| Evidence | Citation |
|---|---|
| Systematic Review + Meta-Analysis | Cheema S, et al. New daily persistent headache: A systematic review and meta-analysis. Cephalalgia. 2023. PMID: 37032616 |
| Systematic Review + Meta-Analysis (2025) | Osiowski M, et al. Epidemiology of new daily persistent headache. Headache. 2025. PMID: 40864527 |
| Practice Guideline | Sico JJ, et al. 2023 VA/DoD Clinical Practice Guideline for Headache. Ann Intern Med. 2024. PMID: 39467289 |
| IHS Diagnostic Framework | Do TP, et al. Updates in the Diagnostic Approach of Headache. Curr Pain Headache Rep. 2021. PMID: 34894320 |
| Primary vs. Secondary DDx | Hernandez J, et al. Headache Disorders: Differentiating Primary and Secondary Etiologies. J Integr Neurosci. 2024. PMID: 38419454 |
| Classification | ICHD-3 Criteria for NDPH |